Retatrutide 10mg
A triple GIP/GLP-1/glucagon receptor agonist studied in metabolic research.
£48.75 · Metabolic & weight · CAS 2381089-83-2
Description
Retatrutide is a tri-agonist peptide targeting the GIP, GLP-1 and glucagon receptors, studied in laboratory research on energy metabolism and weight-regulation pathways. For in-vitro research use only.
Supplied with a written specification and CAS number 2381089-83-2, dispatched from our UK and EU warehouses in discreet, thermally protected packaging. Use our reconstitution calculator to turn vial mass and solvent volume into a documented concentration.
Specification
| CAS number | 2381089-83-2 |
|---|---|
| Molecular formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Molecular weight | 4731.42 g/mol |
| Sequence / identity | GIP/GLP-1/glucagon triple agonist, 39 aa |
| Purity | ≥98% (HPLC) |
| Physical form | Lyophilised powder |
| Research area | Metabolic & weight |
| Storage | Store lyophilised at −20 °C, protected from light. After reconstitution, keep at 2–8 °C. |
| Reconstitution | Reconstitute with bacteriostatic water or 0.9% sodium chloride. |
Frequently asked questions
Is Retatrutide 10mg suitable for human use?
No. Retatrutide 10mg is supplied strictly for in-vitro laboratory research, not for human or veterinary use. You must be 18 or over to place an order.
What purity is Retatrutide 10mg?
≥98% by HPLC. Every vial ships with a written specification and its CAS number (2381089-83-2).
How should Retatrutide 10mg be stored?
Store lyophilised at −20 °C, protected from light. After reconstitution, keep refrigerated at 2–8 °C.
How is Retatrutide 10mg shipped?
Cold-chain packed and dispatched from our UK and EU warehouses in 3–5 working days. Shipped once payment has been received.
Related research peptides
All products are supplied strictly for in-vitro laboratory research. Not for human or veterinary use. Over-18s only.